Advertisement
Search for

Volume 132, Issue 3, Pages 966-981 (March 2007)


View previous. 35 of 75 View next.

Identification of a Chemokine Network That Recruits FoxP3+ Regulatory T Cells Into Chronically Inflamed Intestine

Seung G. Kang, Ronald J. Piniecki, Harm Hogenesch, Hyung W. Lim, Eric Wiebke, Stephen E. Braun§, Satoshi Matsumoto, Chang H. KimCorresponding Author Informationemail address

Received 16 August 2006; accepted 7 December 2006. published online 08 January 2007.

Background & Aims: It has been unclear which chemokine network is involved in migration of T-cell subsets to chronically inflamed lesions of the intestine. SAMP1/YP mice develop a spontaneous chronic transmural intestinal lesion specifically in the ileum. Using these mice, we investigated the gut chemokine network involved in specific migration of T-cell subsets to the inflamed lesion of the intestine. Methods: We performed expression analyses of chemokines and their receptors, chemokine receptor blocking studies, and migration studies in vitro and in vivo to identify the gut chemokine network induced in intestinal inflammation and to determine its role in migration of conventional and FoxP3+ suppressor T cells to the inflamed intestine. Results: The expression of homeostatic chemokines was largely unchanged in the inflamed lesion of SAMP1/YP mice compared with control mice. However, an additional chemokine axis (CCL5-CCR5) was up-regulated in the inflamed intestine of SAMP1/YP mice compared with control mice. Activated T cells of SAMP1/YP mice compared with control mice were hyperresponsive to CCL5 in chemotaxis. CCR5+ T cells preferentially migrated to the inflamed lesion, which can be blocked by a CCR5 antagonist. Importantly, the FoxP3+ regulatory T cells of the inflamed lesion of SAMP1/YP mice highly expressed CCR5. CCR5 blockade suppressed the migration of FoxP3+ T cells into the inflamed intestine and significantly exacerbated the intestinal inflammation. Conclusions: The CCL5-CCR5 chemokine axis is involved in preferential recruitment of FoxP3+ regulatory T cells, which prevents further exacerbation of chronic inflammation in the intestine.

 Laboratory of Immunology and Hematopoiesis, Department of Comparative Pathobiology, Purdue Cancer Center, Purdue University Life Science Program, Purdue University, West Lafayette, Indiana

 Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana

§ Division of Immunology, New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts

 Yakult Central Institute for Microbiological Research, Tokyo, Japan

Corresponding Author InformationAddress requests for reprints to: Chang H. Kim, PhD, VPTH 126, 725 Harrison Street, Purdue University, West Lafayette, Indiana 47907. fax: (765) 494-9830.

 Supported in part by grants from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (AI063064), the Eli and Edythe L. Broad Medical Foundation, the Sidney Kimmel Foundation, and the American Heart Association (to C.H.K.) and by research fellowships from Purdue Research Foundation (S.G.K.), ARP (H.W.L.), and Indiana University School of Medicine, Lafayette (R.J.P.).

PII: S0016-5085(07)00010-8

doi:10.1053/j.gastro.2007.01.008


View previous. 35 of 75 View next.

Advertisement